FDA DEVICE FACTS
OSPREY Closed IV Catheter System (OspreyV2)
Skydance Vascular, Inc.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
OSPREY Closed IV Catheter System (OspreyV2) is an intravascular catheter intended to be inserted into the patient’s vascular system for short-term use to sample blood, monitor blood pressure, or administer fluids intravenously. Blood is contained within the device during the catheter insertion process aiding in the prevention of blood exposure. This catheter may be used for any patient population with consideration given to adequacy of vascular anatomy and appropriateness of procedure.
The OSPREY Closed IV Catheter System (OspreyV2) is suitable for use with power injectors rated for a maximum of 325 psi when connected to male luer lock. An intravascular catheter is intended to be inserted into the patient’s vascular system for short term use to sample blood, monitor blood pressure, or administer fluids intravenously. The NexivaTM intravascular catheter is inserted into a patient's vascular system for a short-term use (less than 30 days) to sample blood, monitor blood pressure, or administer fluids intravascularly. The needle-shielding feature and luer access port, aid in the prevention of needle-stick injuries. Blood is contained within the device during the catheter insertion process aiding in the prevention of blood exposure. This catheter may be used for any patient population with consideration given to adequacy of vascular anatomy and appropriateness of procedure. The 18-22 gauge NexivaTM catheters are suitable for use with power injectors rated for a maximum of 300 psi when the luer access port(s) is removed and a direct connection is made.
Similar
Primary Predicate: Subject device IFU is expanded to include its suitability for use with power injectors and any patient population based on vascular anatomy and appropriateness of procedure.
Secondary Predicate: Subject device IFU is consistent with its suitability for use with power injectors and any patient population based on vascular anatomy and appropriateness of procedure.
Comment #1 Critical Procedural Steps Remove the device from the packaging and inspect before use. Remove the device from the packaging and inspect before use. Remove the device from the packaging and inspect before use. Identical Page - 4 - of 11 Attribute Subject – OSPREY Closed IV Catheter System (OspreyV2) Primary Predicate (A) – OSPREY PERIPHERAL IV Catheter System (K223018) Secondary Predicate (B) – BD Nexiva Closed IV Catheter System (K102520)
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。